JPS52134027A - Antiitumor agent - Google Patents

Antiitumor agent

Info

Publication number
JPS52134027A
JPS52134027A JP5194477A JP5194477A JPS52134027A JP S52134027 A JPS52134027 A JP S52134027A JP 5194477 A JP5194477 A JP 5194477A JP 5194477 A JP5194477 A JP 5194477A JP S52134027 A JPS52134027 A JP S52134027A
Authority
JP
Japan
Prior art keywords
antiitumor
agent
antiitumor agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5194477A
Other languages
English (en)
Other versions
JPS6146455B2 (ja
Inventor
Geruharuto Mundaa Pauru
Buesutofuaaru Otsutoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of JPS52134027A publication Critical patent/JPS52134027A/ja
Publication of JPS6146455B2 publication Critical patent/JPS6146455B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP5194477A 1976-05-04 1977-05-04 Antiitumor agent Granted JPS52134027A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2619686A DE2619686C2 (de) 1976-05-04 1976-05-04 Verwendung eines Lysolecithins zur Tumorbehandlung

Publications (2)

Publication Number Publication Date
JPS52134027A true JPS52134027A (en) 1977-11-09
JPS6146455B2 JPS6146455B2 (ja) 1986-10-14

Family

ID=5977045

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5194477A Granted JPS52134027A (en) 1976-05-04 1977-05-04 Antiitumor agent

Country Status (15)

Country Link
JP (1) JPS52134027A (ja)
AU (1) AU517586B2 (ja)
BE (1) BE854270A (ja)
CA (1) CA1094455A (ja)
DE (1) DE2619686C2 (ja)
FR (1) FR2364656A1 (ja)
GB (1) GB1583661A (ja)
IE (1) IE44927B1 (ja)
IL (1) IL51988A (ja)
IT (1) IT1071329B (ja)
LU (1) LU77248A1 (ja)
NL (1) NL189672C (ja)
NZ (1) NZ183981A (ja)
SE (1) SE7705071L (ja)
ZA (1) ZA772649B (ja)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5396311A (en) * 1977-01-29 1978-08-23 Toyama Chem Co Ltd Anti-cander drugs containing lysolecithins
JPS5528955A (en) * 1978-08-24 1980-02-29 Toyama Chem Co Ltd Novel glycerophosphoric acid derivative, its salt, their preparation, and carcinostatic agent containing the same.
JPS6294A (ja) * 1986-05-09 1987-01-06 Toyama Chem Co Ltd 新規なグリセロリン酸誘導体およびその塩並びにそれらの製造法
EP0209239A1 (en) 1985-07-15 1987-01-21 Takeda Chemical Industries, Ltd. 2-Alkanoyloxypropane derivatives, their production and use
JP2010508836A (ja) * 2006-11-10 2010-03-25 アルファプトーゼ ゲーエムベーハー 受容体リガンド模倣体を検出する方法および組成物

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2046092B (en) 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
US4408052A (en) * 1980-02-27 1983-10-04 Takeda Chemical Industries, Ltd. Phospholipid carbamates
US4551532A (en) * 1980-05-08 1985-11-05 Takeda Chemical Industries, Ltd. Ethylene glycol derivatives having anti-protozoan, anti-fungal and anti-tumor activity
US4444766A (en) * 1980-10-21 1984-04-24 Boehringer Mannheim Gmbh Sulfur-containing phospholipid compounds and therapeutic compositions
JPS5772914A (en) 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
EP0061872B1 (en) * 1981-03-30 1985-08-07 Takeda Chemical Industries, Ltd. Ethyleneglycol derivatives, their production and use
DE3127503A1 (de) * 1981-07-11 1983-02-17 Boehringer Mannheim Gmbh, 6800 Mannheim Neue phospholipide, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3131524A1 (de) * 1981-08-08 1983-02-24 Röhm GmbH, 6100 Darmstadt Verfahren zur herstellung physiologischer effektoren
US4562179A (en) * 1982-04-19 1985-12-31 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, and pharmaceutical composition of the same
DE3239858A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue d-mannitderivate als ausgangsprodukte zur synthese von phospholipiden
DE3239817A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue glycerinderivate zur synthese von phospholipiden
EP0103877B1 (en) * 1982-09-21 1987-01-07 Fujisawa Pharmaceutical Co., Ltd. Phosphate derivatives, process for preparation thereof and pharmaceutical compositions of the same
US4710579A (en) * 1984-11-09 1987-12-01 Takeda Chemical Industries, Ltd. 2-(acetoacetyloxy)-3-(octadecyloxy)propyl-3-trimethylammoniopropyl phosphate or a pharmaceutically acceptable salt thereof
US4761404A (en) * 1985-07-01 1988-08-02 Merck & Co., Inc. Phospholipid analogs useful as PAF synthesis inhibitors
JP2561478B2 (ja) * 1986-07-22 1996-12-11 武田薬品工業株式会社 グリセリン誘導体
US4888328A (en) * 1988-03-10 1989-12-19 Hoeschst-Roussel Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
US5036152A (en) * 1988-03-10 1991-07-30 Hoechst-Roussel Pharmaceuticals Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
DE3918082A1 (de) * 1989-06-02 1991-01-24 Max Planck Gesellschaft Mittel gegen autoimmunerkrankungen
DE3935580C2 (de) * 1989-10-25 1998-05-28 Medmark Pharma Gmbh Verwendung eines pharmazeutischen Wirkstoffes zur Behandlung von HIV-Infektionen
WO1992019627A2 (en) * 1991-04-25 1992-11-12 The University Of British Columbia Phosphonates and phosphinates as anti-cancer, -inflammatory, -allergy and -myocarditis agents
ES2034885B1 (es) * 1991-07-10 1994-03-01 Menarini Lab Procedimiento para la preparacion de cetoalquilglicerofosfolipidos.
CA2199179A1 (en) * 1994-10-14 1996-04-25 Eric Mayhew Ether lipid liposomes and their therapeutic use
US6667053B1 (en) 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
US6007839A (en) * 1996-02-16 1999-12-28 The Liposome Company, Inc. Preparation of pharmaceutical compositions containing etherlipid-containing multiple lipid liposomes
US5965159A (en) * 1996-02-16 1999-10-12 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US5942246A (en) * 1996-02-16 1999-08-24 The Liposome Company, Inc. Etherlipid containing multiple lipid liposomes
USRE39042E1 (en) * 1996-02-16 2006-03-28 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US6135426A (en) * 1998-01-07 2000-10-24 Briggs And Stratton Corporation Priming system for internal combustion engines
RU2009121838A (ru) 2006-11-10 2010-12-20 Альфаптозе ГмбХ (DE) Пероральная лекарственая форма, содержащая соединения тризамещенного глицерина
CN101616676B (zh) * 2006-12-20 2015-09-09 汉堡-艾本德大学医学中心 三取代的甘油化合物用于治疗恶性血液病的应用
US8637688B2 (en) * 2006-12-20 2014-01-28 Julia Diederichs Topical dosage form comprising tri-substituted glycerol compounds
WO2013156630A1 (en) 2012-04-20 2013-10-24 Alphaptose Gmbh S-enantiomer of a tri-substituted glycerol compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009342C3 (de) * 1970-02-27 1980-12-18 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Glycerin-alkyläther-(l)-phosphorsäure-(3)-monocholinestern
DE2009341C3 (de) * 1970-02-27 1979-06-21 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen 3-Octadecyloxy-propanol-(l)-phosphorsäure-monocholinester und Verfahren zu dessen Herstellung
DE2009343C3 (de) * 1970-02-27 1980-10-23 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Lysolecithinen als immunologische Adjuvantien
DE2033361C3 (de) * 1970-07-06 1980-02-21 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Acylpropandiol-(13)-phosphorsäurecholinester und Verfahren zu deren Herstellung

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5396311A (en) * 1977-01-29 1978-08-23 Toyama Chem Co Ltd Anti-cander drugs containing lysolecithins
JPS5742046B2 (ja) * 1977-01-29 1982-09-07
JPS5528955A (en) * 1978-08-24 1980-02-29 Toyama Chem Co Ltd Novel glycerophosphoric acid derivative, its salt, their preparation, and carcinostatic agent containing the same.
JPS6338322B2 (ja) * 1978-08-24 1988-07-29 Toyama Chemical Co Ltd
EP0209239A1 (en) 1985-07-15 1987-01-21 Takeda Chemical Industries, Ltd. 2-Alkanoyloxypropane derivatives, their production and use
JPS6294A (ja) * 1986-05-09 1987-01-06 Toyama Chem Co Ltd 新規なグリセロリン酸誘導体およびその塩並びにそれらの製造法
JPS6315278B2 (ja) * 1986-05-09 1988-04-04 Toyama Chemical Co Ltd
JP2010508836A (ja) * 2006-11-10 2010-03-25 アルファプトーゼ ゲーエムベーハー 受容体リガンド模倣体を検出する方法および組成物

Also Published As

Publication number Publication date
BE854270A (fr) 1977-11-04
LU77248A1 (ja) 1977-12-13
SE7705071L (sv) 1977-11-05
NL189672B (nl) 1993-01-18
IL51988A0 (en) 1977-07-31
NL189672C (nl) 1993-06-16
JPS6146455B2 (ja) 1986-10-14
DE2619686A1 (de) 1977-11-24
FR2364656B1 (ja) 1980-03-07
IT1071329B (it) 1985-04-02
CA1094455A (en) 1981-01-27
AU2481977A (en) 1978-11-09
DE2619686C2 (de) 1986-08-07
IE44927L (en) 1977-11-04
GB1583661A (en) 1981-01-28
FR2364656A1 (fr) 1978-04-14
IE44927B1 (en) 1982-05-19
IL51988A (en) 1981-05-20
ZA772649B (en) 1978-04-26
NL7704723A (nl) 1977-11-08
NZ183981A (en) 1980-04-28
AU517586B2 (en) 1981-08-13

Similar Documents

Publication Publication Date Title
JPS52134027A (en) Antiitumor agent
JPS52145525A (en) Local antiiinflammation agent
AU2384277A (en) Triazolo-pyrimidines
JPS5325525A (en) Radiooopaque agent
JPS5470433A (en) Antiiulcer agent
JPS5299230A (en) Antiitumor agent
JPS52118497A (en) Antiiallergy agent
AU2451277A (en) Isothiazolopyridines
JPS5297933A (en) Antiihypertensive agent
JPS535195A (en) Antiibacterial agent
JPS52117436A (en) Antiicoccidium agent
JPS5335084A (en) Airzol size agent
SU725543A3 (en) Insecticidic agent
JPS5386040A (en) Antiicoagulating agent
JPS5372828A (en) Antiicancer agent
JPS5297963A (en) Antiihypertensive agent
JPS52114025A (en) Antiitumor agent
JPS5379012A (en) Antiicancer agent
JPS5297967A (en) Antiihypertensive agent
JPS5377055A (en) Antiilinoovirus agent
JPS5335085A (en) Airzol size agent
JPS5331693A (en) Antiibacterial agents
JPS52130932A (en) Antiisolidifying agent
ZA776789B (en) Antirhinovirus agents
CY1158A (en) Arylmalonamido-1-oxadethiacephalosporins